%0 Journal Article
%T 胃癌新辅助化疗的研究进展<br>Research Progress of Neoadjuvant Chemotherapy for Gastric Cancer
%A 韩琪琪
%A 马金华
%J Advances in Clinical Medicine
%P 4648-4652
%@ 2161-8720
%D 2021
%I Hans Publishing
%R 10.12677/ACM.2021.1110683
%X 胃癌是消化系统常见的恶性肿瘤，发病率和病死率均较高。以手术和化疗为主的综合治疗是胃癌的标准治疗方式，胃癌新辅助化疗作为胃癌综合治疗的一部分已得到越来越多的关注，其在胃癌治疗中的地位日趋重要。虽然新辅助化疗能够改善胃癌患者的治疗效果，但西方国家和东亚国家对于具体的用药方案尚未形成共同的理念。<br />
Gastric cancer is a common malignant tumor of digestive system, with high incidence and mortality. The comprehensive treatment based on surgery and chemotherapy is the standard treatment for gastric cancer. Neoadjuvant chemotherapy for gastric cancer, as a part of comprehensive treatment for gastric cancer, has attracted more and more attention, and its position in the treatment of gastric cancer is becoming more and more important. Although neoadjuvant chemotherapy can improve the therapeutic effect of gastric cancer patients, western countries and East Asian countries have not formed a common concept for specific drug regimens.
%K 胃癌，新辅助化疗，疗效<br>Gastric Cancer
%K Neoadjuvant Chemotherapy
%K Curative Effect
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=45901